Patent Law Alert: In Life Technologies Corp. v. Promega Corp., U.S. Supreme Court Held That Supply of a Single Component of a Multicomponent Invention for Manufacture Abroad Does Not Give Rise to Liability for Patent Infringement Under 35 U.S.C. § 271(f)(1)

On February 22, 2017, the United States Supreme Court issued its decision in Life Technologies Corp. v. Promega Corp., unanimously reversing the United States Court of Appeals for the Federal Circuit’s decision that the supply of a single component of a multicomponent invention for manufacture abroad may trigger liability for patent infringement under 35 U.S.C. […]